SCHEMBL13261590

SCHEMBL13261590

CCOC(=O)C(C(=O)c1ccc(CS(=O)O)cc1)c1ccc2ccccc2c1

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ SLC6A2 P23975 2/20 0.38
▸ SLC6A4 P31645 2/20 0.38
▸ SLC6A3 Q01959 2/20 0.38
▸ CYP2D6 P10635 1/20 0.38
▸ KCNH2 Q12809 1/20 0.38
▸ HDAC1 Q13547 3/20 0.37
▸ MMP8 P22894 1/20 0.36
▸ GAA P10253 1/20 0.36
▸ OPRM1 P35372 1/20 0.36
▸ OPRD1 P41143 1/20 0.36
▸ CNR2 P34972 1/20 0.36
▸ GABBR2 O75899 1/20 0.35
▸ GABBR1 Q9UBS5 1/20 0.35
▸ P2RY12 Q9H244 1/20 0.35
▸ HDAC3 O15379 2/20 0.35
▸ HDAC2 Q92769 2/20 0.35
▸ GLA P06280 1/20 0.35
▸ NPC1 O15118 1/20 0.34
▸ RAB9A P51151 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13228110 0.85 NPC1 (0.44) SLC6A2SLC6A4SLC6A3CYP2D6KCNH2
SCHEMBL7925167 0.84 MMP8 (0.47) SLC6A2SLC6A4SLC6A3CYP2D6KCNH2
SCHEMBL13261545 0.84 SLC6A2 (0.42) SLC6A2SLC6A4SLC6A3GAA
SCHEMBL13261834 0.83 MMP8 (0.38) SLC6A2SLC6A4SLC6A3MMP8GAA
SCHEMBL13261551 0.83 L3MBTL1 (0.41) HDAC1OPRM1OPRD1NPC1RAB9A
SCHEMBL13261592 0.83 CES2 (0.39) SLC6A2SLC6A3MMP8
SCHEMBL13261548 0.83 TSHR (0.42) GAACNR2NPC1RAB9A
SCHEMBL13261549 0.83 CA12 (0.43) SLC6A2SLC6A4SLC6A3HDAC1CNR2
SCHEMBL13261550 0.82 MMP8 (0.35) MMP8GAA
SCHEMBL13261556 0.82 CA12 (0.43) GAANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7781592-B2 Thione derivative, method for the preparation thereof, and pharmaceutical composition containing the same CJ CHEILJEDANG CORPORATION (KR) 2010-08-24 — — US disclosed
US-20080090875-A1 Thione Derivative, Method For The Preparation Thereof, And Pharmaceutical Composition Containing The Same CJC CORPORATION (KR) 2008-04-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080090875-A1 Thione Derivative, Method For The Preparation Thereof, And Pharmaceutical Composition Containing The Same TPMT, TST, CYP3A5 SLC6A2 1291/4885SLC6A4 640/4885SLC6A3 551/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback